Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.
Concerns stem from manufacturing and distribution of the BioZorb marker, with possible ramifications including "seizure, injunction and civil money penalties."
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.